<DOC>
	<DOCNO>NCT01210677</DOCNO>
	<brief_summary>There publish clinical consensus guideline treatment cardiac sarcoidosis . Corticosteroid therapy advocate expert , base small observational study , vary clinical response . Objectives trial : - systemically assess response patient cardiac sarcoidosis , treatment corticosteroid - identify clinical predictor response treatment corticosteroid - ass utility image PET MRI predict response treatment corticosteroid - determine prevalence cardiac sarcoidosis young patient unexplained heart block patient unexplained dilate cardiomyopathy associate ventricular tachycardia - use data pilot study ass need , feasibility , sample size large multicentre trial</brief_summary>
	<brief_title>Cardiac Sarcoidosis Response To Steroids Trial</brief_title>
	<detailed_description />
	<mesh_term>Sarcoidosis</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<criteria>evidence clinical cardiac sarcoidosis cause significant conduction system disease ( defined complete right bundle branch block leave axis deviation leave bundle branch block second third degree AV block young patient ( &lt; 60 yr ) AND/OR evidence clinical cardiac sarcoidosis cause nonischemic dilate cardiomyopathy sustain ventricular tachycardia AND PET MRI image support diagnosis cardiac sarcoidosis unable unwilling provide inform consent history noncompliance medical therapy patient active infection patient active inflammatory disease related sarcoidosis patient know cause heart block LV dysfunction patient know active malignancy patient wwho pregnant lactating patient indication steroid</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Cardiac Sarcoidosis</keyword>
	<keyword>Sarcoidosis</keyword>
</DOC>